Nurse Anesthetist - CR in Binghamton, NY Accepting Medicare

10 Nurse Anesthetist - CR nurses found. Showing 1 - 10

Deborah D Clarhaut, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Drive, Binghamton, NY 13905 Phone: 160-772-2726

Maureen Coyle, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: Riverside Associates, 40 Front Street, Binghamton, NY 13905 Phone: 607-722-7264    Fax: 607-722-7869

Patricia Nezelek, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: Riverside Associates, 40 Front St., Binghamton, NY 13905 Phone: 607-722-7264    Fax: 607-722-7869

Bridget Misura, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Lourdes Hospital, Binghamton, NY 13905 Phone: 607-722-7264

Joseph Slavetskas, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: Riverside Associates, 40 Front St., Binghamton, NY 13905 Phone: 607-722-7264    Fax: 607-722-7869

Daniella Fabian, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-722-7264    Fax: 607-722-7869

Shawn Patrick Sparks, GRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 600-772-2726

Robtrina Ferebee, Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 40 Front St, Suite C, Binghamton, NY 13905 Phone: 607-722-7264

Ryan M Volk, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: Riverside Associates, 40 Front St., Binghamton, NY 13905 Phone: 607-722-7264    Fax: 607-722-7869

Timothy Foster, GRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-722-7264

News Archive

GSK seeks regulatory approval in U.S., Europe for Tykerb

GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.

EntreMed adds DF/HCC hospitals to Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.

Merlin and Hippo proteins interact to begin chain of events that control tissue growth

Johns Hopkins researchers have figured out the specific job of a protein long implicated in tumors of the nervous system. Reporting on a new study described in the Sept. 12 issue of the journal Cell, they detail what they call the "matchmaking" activities of a fruit fly protein called Merlin, whose human counterpart, NF2, is a tumor suppressor protein known to cause neurofibromatosis type II when mutated.

NIH awards UF scientists $7.5M for study of MRI technology in evaluating children with DMD

Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.

Read more Medical News

› Verified 6 days ago